Global Cord Blood (CORBF) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Global Cord Blood Corporation, currently in provisional liquidation, has encountered challenges with its extraordinary general meeting (EGM), which was adjourned and eventually dissolved due to a lack of quorum. The Joint Provisional Liquidators (JPLs) have since sought court approval for their remuneration for the period between September 2022 and September 2023. Shareholders have been notified of the developments and the court hearing for the JPLs’ remuneration approval is scheduled for July 30, 2024.
For further insights into CORBF stock, check out TipRanks’ Stock Analysis page.